Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
LXEO
Shares outstanding
55,563,667 shares
Disclosed Ownership
5,334,112 shares
Ownership
9.6%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:58:22 UTC
Date of event
30 Jun 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 9.6% ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO) on 30 Jun 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO).
  • Disclosed ownership: 9.6%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 16:58.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 9.6% 5,325,269 0 5,325,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 9.6% 5,325,269 0 5,325,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 9.6% 5,325,269 0 5,325,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 8,843 0 8,843 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0% 8,843 0 8,843 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0% 8,843 0 8,843 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 9.6% 5,334,112 0 5,334,112 /s/ Seth Levy Seth Levy, attorney-in-fact*